Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.01 is 36% below its 5-year average of 4.68, near the low end of its 5-year range (0.14–26.62).
As of the fiscal period ended Friday, July 31, 2026. 20.39% below its 12-month average of 3.79.
Reported quarterly current ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 3.01.
CURRENT RATIO
3.01
CURRENT RATIO AVG TTM
3.79
CURRENT RATIO AVG 3Y
2.82
CURRENT RATIO AVG 5Y
4.68
CURRENT RATIO AVG 10Y
3.27
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.39%
CURRENT VS 3Y AVG
+6.96%
CURRENT VS 5Y AVG
-35.57%
CURRENT VS 10Y AVG
-7.84%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
-15.83%
vs the sector median at left
Market Cap
$5.24M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
Market Cap
$5.23M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
Market Cap
$5.17M
Current Ratio
1.12
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.12
Market Cap
$5.15M
Current Ratio
1.88
TTM Avg
1.74
3Y Avg
1.99
5Y Avg
1.99
Market Cap
$5.60M
Current Ratio
11.70
TTM Avg
17.23
3Y Avg
23.62
5Y Avg
22.05
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.25M | 3.01 | 3.79 | 2.82 | 4.68 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | 1.44 | 1.10 | 1.11 | 1.95 |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | 4.70 | 11.62 | 9.04 | 8.74 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | 0.09 | 0.18 | 0.44 | 0.97 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.19 | 0.06 | 0.46 | 2.58 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | 1.12 | 0.07 | 0.07 | 0.12 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.15M | 1.88 | 1.74 | 1.99 | 1.99 |
| Imunon, Inc. (IMNN)vs › | $5.08M | 1.82 | 1.99 | 2.53 | 3.43 |
| enVVeno Medical Corporation (NVNO)vs › | $5.60M | 11.70 | 17.23 | 23.62 | 22.05 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.72M | 3.88 | 2.19 | 2.86 | 5.66 |
Current Ratio
3.01
Quick Ratio
3.01
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-07-31 | 3.01 |
| 2026-04-30 | 1.31 |
| 2026-01-31 | 1.99 |
| 2025-10-31 | 6.58 |
| 2025-07-31 | 6.03 |
| 2025-04-30 | 6.58 |
| 2025-01-31 | 5.44 |
| 2024-10-31 | 3.80 |
| 2024-07-31 | 0.49 |
| 2024-04-30 | 0.14 |
| 2024-01-31 | 0.16 |
| 2023-10-31 | 0.21 |
| 2023-07-31 | 0.88 |
| 2023-04-30 | 2.03 |
| 2023-01-31 | 3.19 |
| 2022-10-31 | 6.31 |
| 2022-07-31 | 11.78 |
| 2022-04-30 | 12.37 |
| 2022-01-31 | 26.62 |
| 2021-10-31 | 9.83 |
| 2021-07-31 | 11.41 |
| 2021-04-30 | 3.24 |
| 2021-01-31 | 0.38 |
| 2020-10-31 | 0.00 |
| 2020-07-31 | 0.00 |
| 2020-04-30 | 1.83 |
| 2020-01-31 | 0.00 |
| 2019-10-31 | 4.78 |
| 2019-07-31 | 4.78 |
| 2019-04-30 | 1.27 |
| 2019-01-31 | 1.27 |
| 2018-10-31 | 4.40 |
| 2018-07-31 | 4.40 |
| 2018-04-30 | 24.98 |
| 2018-01-31 | 24.98 |
| 2017-10-31 | 0.90 |
| 2017-07-31 | 0.90 |
| 2017-04-30 | 0.08 |
| 2017-01-31 | 0.08 |
| 2016-10-31 | 1.20 |
| 2016-07-31 | 1.20 |
